Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2016 |
Nov. 30, 2015 |
Nov. 30, 2016 |
Nov. 30, 2015 |
|
| Condensed Consolidated Statements Of Operations And Comprehensive Loss | ||||
| Revenue | ||||
| Operating Expenses | ||||
| General and administrative | 277,951 | 416,700 | 1,034,007 | 1,134,986 |
| Research and development | 368,403 | 240,085 | 1,217,600 | 499,924 |
| Depreciation and amortization | 102,244 | 78,613 | 290,396 | 104,822 |
| Cost of reverse merger | 60,571 | |||
| Foreign exchange loss (gain) | 809 | 8,441 | (2,880) | 9,453 |
| Total operating expenses | 749,407 | 743,839 | 2,539,123 | 1,809,756 |
| Net Loss | (749,407) | (743,839) | (2,539,123) | (1,809,756) |
| Other comprehensive loss - | ||||
| Foreign currency translation adjustment | (18,488) | (64,566) | (42,846) | (11,505) |
| Comprehensive Loss | $ (767,895) | $ (808,405) | $ (2,581,969) | $ (1,821,261) |
| Loss per share - Basic and Diluted | $ (0.02) | $ (0.02) | $ (0.08) | $ (0.07) |
| Weighted average common shares outstanding - Basic and Diluted | 31,390,807 | 29,810,800 | 31,001,702 | 26,533,037 |